Therapeutic Initial Heparin Dosing for Patients With Clots or Certain Heart Conditions Admitted to the Hospital

A phase 4 trial registered on ClinicalTrials.gov. The registry status is active, not recruiting. It plans to enroll 145 participants.

Also called NCT07250763

  • Study
  • In this atlas

Overview

Design
Interventional study; allocation not applicable; no masking; primary purpose treatment
Phase
Phase 4
Enrolled
  • 145 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT07250763
Started
(actual) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
United States (from the registry)
Registry status
  • Active, not recruiting (from the registry)

Technical summary

Registry record NCT07250763. Allocation not applicable; no masking; primary purpose treatment. Start 2023-09-20 (actual); primary completion 2027-02-28 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Therapeutic Initial Heparin Dosing for Patients With Clots or Certain Heart Conditions Admitted to the Hospital
Condition
Acute Cardiac Syndrome
Condition
Mechanical Heart Valve Recipients
Intervention (Drug)
Initial Heparin Dose Modification
Lead sponsor
Inova Health Care Services (class: other)

Record details

Record id
cardio:ct-nct07250763
Content hash
44a17c564b35b26ef06545fcf47f16b8d59206c88b2153a12fe935cb4eb54605